Furthermore, downregulating CPT1A decreased cell motility in ARMS cells, indicating that CPT1A is a downstream effector of PAX3-FKHR–mediated cell migration and metastasis. The gene discussed is FOXO1; the disease is alveolar rhabdomyosarcoma.